Fig. 4: Imaging subtypes were prognostic for recurrence-free survival in NSCLC patients. | Nature Communications

Fig. 4: Imaging subtypes were prognostic for recurrence-free survival in NSCLC patients.

From: Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights

Fig. 4

Kaplan-Meier curve comparing RFS of individuals with low risk (green), high risk (red), and intermediate risk (purple) subtypes with P = 1e-05 by log-rank test in the discovery cohort (a) and P = 0.024 by log-rank test in the validation cohort (b). Kaplan-Meier curve comparing OS of individuals with low risk (green), high risk (red), and intermediate risk (purple) subtypes with P = 0.037 by log-rank test in the training cohort (c) P = 0.0017 by log-rank test in the internal validation cohort (d) and P = 0.0201 by log-rank test in the external validation cohort (e). Source data are provided as a Source Data file.

Back to article page